At 27, engineer Léonie Schroder is developing the Huvy application alongside Bryan Boulé, designed to rapidly detect the severity of skin lesions using an algorithm that analyzes photographs. The project is driven by extended wait times to consult dermatologists, even as the incidence of melanoma has risen sharply in recent decades. The founders assembled a database of approximately 35,000 images, enabling the algorithm to stratify lesions into three risk categories, thereby facilitating either referral to a specialist or routine monitoring. Initial trials demonstrated a predictive accuracy of approximately 90%; however, the application remains in the certification phase required for market authorization, a process that requires considerable time. The solution is expected to be offered to general practitioners, pharmacists, and nurses via a subscription model, with targeted availability in early 2024. The project developers have invested nearly €450,000 in its development and emphasize that the device serves as an adjunctive diagnostic tool, not a replacement for physicians.




